Neurocrine Biosciences
NBIX
#1354
Rank
A$23.87 B
Marketcap
A$237.42
Share price
-10.08%
Change (1 day)
19.33%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company